This means that when the image is focused behind the retina, the mRNA is regulated negatively and the vitreous chamber is enlarged, therefore suggesting that the BMP2 gene plays a bidirectional role in modulating ocular growth and that the BMP2 gene could be used in therapeutic interventions for controlling myopia [21]. The gene discussed is BMP2; the disease is myopia.